Craft

Theravectys

Total Funding

$31.7 M

Theravectys Summary

Company Summary

Overview
Theravectys is a vaccine company. It leverages a platform to deliver T-cell vaccines. Its vaccines help to modulate the immune response through gene transfer into dendritic cells.
Type
Private
Status
Active
Founded
2005
HQ
Paris, FR | view all locations
Website
https://theravectys.site/
Cybersecurity rating
Sectors

Key People

  • Pierre Charneau, Chief Scientific Officer

    • Jean Chalopin, Chairman

      • Ye Tian, Chief Executive Officer

        LocationsView all

        2 locations detected

        • Paris, IDF HQ

          France

          28 Rue du Dr Roux

        • Paris, IDF

          France

          3 Rue de l'Arrivée

        Footer menu